Dietary restriction does not prevent nigrostriatal degeneration in the 6-hydroxydopamine model of Parkinson's disease

Experimental Neurology

Volumn 212, Issue 2, 2008, Pages 548-551

  Armentero, M T ^a   Levandis, G ^a   Bramanti, P ^c   Nappi, G ^a,b   Blandini, F ^a  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CELL LOSS; CONTROLLED STUDY; DIET RESTRICTION; DOPAMINERGIC NERVE CELL; DRUG INFUSION; FOOD; HISTOLOGY; MALE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RODENT; STRIATONIGRAL DEGENERATION; THERAPY EFFECT;

ANIMALS; CORPUS STRIATUM; DIET THERAPY; DISEASE MODELS, ANIMAL; MALE; NERVE DEGENERATION; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 47349110671     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.04.006     Document Type: Article

References (44)

1. Armentero M.T., Fancellu R., Nappi G., Bramanti P., and Blandini F. Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease. Neurobiol. Dis. 1 (2006) 1-9
2. Armentero M.T., Levandis G., Nappi G., Bazzini E., and Blandini F. Peripheral inflammation and neuroprotection: systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease. Neurobiol. Dis. 3 (2006) 492-505
3. Blandini F., Armentero M.T., Fancellu R., Blaugrund E., and Nappi G. Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease. Exp. Neurol. 2 (2004) 455-459
4. Blandini F., Levandis G., Bazzini E., Nappi G., and Armentero M.T. Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model. Eur. J. Neurosci. 2 (2007) 397-405
5. Bruce-Keller A., Umberger G., McFall R., and Mattson M. Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Ann. Neurol. 45 (1999) 8-15
6. Chaturvedi R.K., Shukla S., Seth K., Chauhan S., Sinha C., Shukla Y., and Agrawal A.K. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Neurobiol. Dis. 2 (2006) 421-434
7. Contestabile A., Ciani E., and Contestabile A. Dietary restriction differentially protects from neurodegeneration in animal models of excitotoxicity. Brain Res. 1-2 (2004) 162-166
8. Dawson T., Mandir A., and Lee M. Animal models of PD: pieces of the same puzzle?. Neuron 35 (1998) 219-222
9. Deumens R., Blokland A., and Prickaerts J. Modelling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol. 2 (2002) 303-317
10. Duan W., and Mattson M. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. Res. 2 (1999) 195-206
11. Duan W., Guo Z., and Mattson M. Brain-derived neurotrophic factor mediates an excitoprotective effect of dietary restriction in mice. J. Neurochem. 2 (2002) 619-626
12. Glinka Y., Gassen M., and Youdim M.B. Mechanism of 6-hydroxydopamine neurotoxicity. J. Neural Transm., Suppl. 50 (1997) 55-66
13. Glinka Y., Tipton K.F., and Youdim M.B. Mechanism of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine. Eur. J. Pharmacol. 1 (1998) 121-129
14. Henze C., Earl C., Sautter J., Schmidt N., Themann C., Hartmann A., and Oertel W. Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesin in rats. Brain Res. 1052 (2005) 97-105
15. Heydari A., You S., et al. Effect of caloric restriction on the expression of hat shock protein 70 and the activation of heat shock transcription factor 1. Dev. Genet. 18 (1996) 114-124
16. Hirsch E.C., Hoglinger G., Rousselet E., Breidert T., Parain K., Feger J., Ruberg M., Prigent A., Cohen-Salmon C., and Launay J.M. Animal models of Parkinson's disease in rodents induced by toxins: an update. J. Neural Transm., Suppl. 65 (2003) 89-100
17. Holmer H.K., Keyghobadi M., Moore C., Menashe R.A., and Meshul C.K. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration. Synapse 2 (2005) 100-112
18. Ingram D., and Weindruch R. Dietary restriction benefits learning and motor performance of aged mice. J. Gerontol. 42 (1987) 78-81
19. Kirik D., Rosenblad C., and Björklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriataldopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp. Neurol. 152 (1998) 259-277
20. Kirik D., Rosenblad C., and Bjorklund A. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor. Eur. J. Neurosci. 11 (2000) 3871-3882
21. Lane M., and Black A. Caloric restriction in primates. Ann. N.Y. Acad. Sci. (2001) 287-295
22. Lee C.-K., and Weindruch R. Gene expression profile of the ageing brain in mice. Nat. Genet. 25 (2000) 294-297
23. Lee J., Bruce-Keller A., Kruman Y., Chan S., and Mattson M. 2-Deoxy-d-glucose protects hippocampal neurons against excitotoxic and oxidative injury: evidence for the involvement of stress proteins. J. Neurosci. Res. 83 (1999) 48-61
24. Lee J., Herma J., and Mattson M. Dietary restriction selectively decreases glucocorticoid receptor expression in the hippocampus and cerebral cortex of rats. Exp. Neurol. 2 (2000) 435-441
25. Lewin P., Janda J.K., Joseph J.A., Ingram D.K., and Roth G.S. Dietary restriction retards the age-associated loss of rat striatal dopaminergic receptors. Science 214 (1981) 561-562
26. Logroscino G., Marder Cote L., Tang M., Shea R., and Mayeux R. Dietary lipids and antioxidant in Parkinson's disease: a population-based, case-control study. Ann. Neurol. 39 (1996) 89-94
27. Martin B., Mattson M.P., and Maudsley S. Caloric restriction and intermittent fasting: two potential diets for successful brain aging. Ageing Res. Rev. 3 (2006) 332-353
28. Mattson M., Duan W., and Guo Z. Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms. J. Neurochem. 3 (2003) 417-431
29. Mattson M. Energy intake, meal frequency, and health: a neurobiological perspective. Annu. Rev. Nutr. 25 (2005) 237-260
30. Mattson M.P., Duan W., Wan R., and Guo Z. Prophylactic activation of neuroprotective stress response pathways by dietary and behavioral manipulations. NeuroRx 1 (2004) 111-116
31. Paul G., Meissner W., Rein S., Harnack D., Winter C., Hosmann K., Morgenstern R., and Kupsch A. Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease. Exp. Neurol. 2 (2004) 272-280
32. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates vol. 2 (1998), Academic Press, San Diego 143 pp.
33. Pedersen W.A., and Mattson M.P. No benefit of dietary restriction on disease onset or progression in amyotrophic lateral sclerosis Cu/Zn-superoxide dismutase mutant mice. Brain Res. 1 (1999) 117-120
34. Poon H.F., Shepherd H.M., Reed T.T., Calabrese V., Stella A.M., Pennisi G., Cai J., Pierce W.M., Klein J.B., and Butterfield D.A. Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: mitochondrial dysfunction, glutamate dysregulation and impaired protein synthesis. Neurobiol. Aging 7 (2006) 1020-1034
35. Roth G., Lane M., Ingram D., and Mattson J. Biomarkers of caloric restriction may predict longevity in humans. Science 297 (2002) 811
36. Sanchez-Iglesias S., Rey P., Mendez-Alvarez E., Labandeira-Garcia J.L., and Soto-Otero R. Time-course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkinson's disease. Neurochem. Res. 1 (2007) 99-105
37. Schober A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res. 318 (2004) 215-224
38. Shimohama S., Sawada H., Kitamura Y., and Taniguchi T. Disease model: Parkinson's disease. Trends Mol. Med. 8 (2003) 360-365
39. Smith M.P., and Cass W.A. Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson's disease. Neuroscience 3 (2007) 1057-1066
40. Sohal R., and Ku H. Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech. Ageing Dev. 74 (1994) 121-133
41. Sohal R., and Weindruch R. Oxidative stress, caloric restriction, and aging. Science (1996) 59-63
42. Weindruch R. How does dietary restriction retard diseases and aging?. Prog. Clin. Biol. Res. 287 (1989) 97-103
43. Weindruch R. Dietary restriction, tumors, and aging in rodents. J. Gerontol. 6 (1989) 67-71
44. Weindruch R., Walford R.L., Fligiel S., and Guthrie D. The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. J. Nutr. 4 (1986) 641-654